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Appraisal Clinical Practice Guidelines
Latest update: January 2009. Next update: In 5 years. 
Patient group: Adults with spasticity due to neurological 
illness or injury. Intended audience: Doctors and health 
professionals involved in the management of spasticity, 
providers and purchasers of rehabilitation services. 
Additional versions: This guideline is an update of a 
previous clinical practice guideline. Turner-Stokes L, Ward 
AB (2002) Guidelines for the use of botulinum toxin in the 
management of spasticity in adults. Concise Guidance to 
Good Practice. London: RCP. Expert working group: Seven 
British experts from a variety of professional backgrounds 
comprised the guideline panel. This included individuals 
with backgrounds in physiotherapy, rehabilitation medicine, 
occupational therapy, and neurology. Funded by: Ipsen 
Ltd. Consultation with: In addition to the four bodies 
below indicating approval, the guidelines were developed 
with the Association of British Neurologists, College of 
Occupational Therapists Specialist Section – Neurological 
Practice, Adult Physiotherapy Spasticity Forum, Society for 
Research in Rehabilitation, and several user representative 
organisations. Approved by: Royal College of Physicians, 
British Society of Rehabilitation Medicine, Chartered 
Society of Physiotherapy, and the Association of Chartered 
Physiotherapists Interested in Neurology. Location: http://
www.rcplondon.ac.uk/pubs/brochure.aspx?e=272
Management of spasticity in adults
Spasticity in adults: management with botulinum toxin
Description: These guidelines consist of three documents: 
the guidelines (41 pages), appendices (36 pages), and 
references. The guidelines document has a useful one 
page executive summary, and a three page summary of 
recommendations with the grade of evidence available 
for each recommendation. The guidelines document itself 
provides background information on topics including: 
spasticity – what it is, management, and treatment 
principles; and botulinum toxin – what it is, how it works, 
administration, dosage guidelines, and adverse effects. 
It details steps and principles in using botulinum toxin to 
treat spasticity including factors such as patient selection, 
treatment goals, muscle selection, and pre and post injection 
management. Examples of tools that may be useful to 
formally evaluate the effectiveness of treatment in terms of 
impairment, activity and participation, are included. The 
appendices document includes detailed evidence tables 
describing the studies that contribute to the recommendation 
levels. This includes studies on the effect of botulinum toxin 
on upper and lower limb spasticity, the use of adjunctive 
therapies such as electrical stimulation, the evidence for 
cost effectiveness, and directions for future research. These 
appendices also include copies of tools to assess outcome 
such as the Modified Ashworth and the Tardieu scales, 
the effect on function (eg, Leeds Arm Spasticity Impact 
Scale, Arm activity measure), and the goal attainment 
scale. Example data collection/patient record sheets and a 
patient advice sheet on the use of botulinum toxin are also 
provided.
Latest update: June 2009. Next update: Not indicated. 
Patient group: Intubated and nonintubated adult patients. 
Intended audience: Physiotherapists, respiratory therapists, 
nurses, and physicians. Additional versions: This guideline 
is an update of a previous clinical practice guideline. Brooks 
D et al (2001) Can Resp J 8: 163–181. Expert working 
group: Six Canadian experts from a variety of professional 
backgrounds comprised the guideline panel. This included 
individuals with backgrounds in physiotherapy, nursing, and 
respiratory therapy. Funded by: Physiotherapy Foundation 
of Canada. Consultation with: Not indicated. Approved by: 
Not indicated. Location: Overend TJ et al (2009) Can Resp 
J 16: e6–17. http://www.pulsus.com/journals/toc.jsp?sCurrP
g=journal&jnlKy=4&isuKy=863
Suctioning adult patients
Suctioning adult patients
Description: This 12 page journal article reviews 
28 randomised trials and 11 lower level studies. The 
guideline presents evidence for the clinical indications 
and precautions for suctioning adult patients. In addition it 
outlines the evidence for the methods and techniques that 
optimise benefits and reduce complications or risks when 
suctioning intubated, nonintubated, or tracheotomised 
adult patients. This includes the use of hyperoxygenation, 
hyperinflation, an adaptor in the ventilator circuit, open 
versus closed suctioning systems, subglottic suctioning, 
minimally invasive suctioning, saline instillation, 
medications administered during suctioning, infection 
control issues, suctioning during different ventilator modes 
and varied suction catheter sizes. Studies are rated using 
scales including the PEDro rating scale. Summary tables of 
all papers contributing to the review are presented. These 
include descriptions of groups and interventions, outcome 
measures and summaries of main results. Meta-analyses 
are undertaken to compare the effect of open vs closed 
suctioning on various outcome measures such as arterial 
oxygen saturation, end-expiratory lung volume, and the 
presence of ventilator associated pneumonia.
